This chapter explores the impacts of weight loss medications on health, focusing on type 2 diabetes and obesity-related conditions. It considers recent findings on their effectiveness, the implications of long-term use, and the interplay of economic factors and treatment combinations for optimal patient outcomes.
Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF.
Bloomberg News Health Care Reporter Madison Muller discusses that patients taking Eli Lilly’s blockbuster weight-loss shot were 94% less likely to develop diabetes in a three-year study that illuminates the long-term health benefits of treating obesity.
Hosts: Tim Stenovec and Katie Greifeld. Producer: Paul Brennan.
See omnystudio.com/listener for privacy information.